A Regulators Viewpoint: Strategies to Evaluate Microphysiological Systems for Drug Development
CN Bio Webinar Series 1 - 2020
Microengineered in vitro platforms that enhance the physiology of the cellular microenvironment have been developed and improved in the last decade for modeling focused properties of several tissues or organs, which are not recreated with traditional in vitro cell culture systems.
Despite published advancements in modeling tissue physiology in vitro, microphysiological systems are not yet routinely used in drug development.
In this webinar, we describe current research efforts being developed in the FDA’s Division of Applied Regulatory Science (CDER), for evaluating microphysiological systems while considering their potential use in drug development.
The department's initial projects have been focused on heart and liver systems and we are now expanding to other organ systems of relevance for evaluating drug effects.
Watch this webinar to learn about:
Challenges in using microphysiological systems as drug development tools
Examples of evaluation efforts of systems as drug development tools
Hepatic and cardiac systems
Key contexts of use in drug evaluation for these systems
Видео A Regulators Viewpoint: Strategies to Evaluate Microphysiological Systems for Drug Development канала CN Bio
Microengineered in vitro platforms that enhance the physiology of the cellular microenvironment have been developed and improved in the last decade for modeling focused properties of several tissues or organs, which are not recreated with traditional in vitro cell culture systems.
Despite published advancements in modeling tissue physiology in vitro, microphysiological systems are not yet routinely used in drug development.
In this webinar, we describe current research efforts being developed in the FDA’s Division of Applied Regulatory Science (CDER), for evaluating microphysiological systems while considering their potential use in drug development.
The department's initial projects have been focused on heart and liver systems and we are now expanding to other organ systems of relevance for evaluating drug effects.
Watch this webinar to learn about:
Challenges in using microphysiological systems as drug development tools
Examples of evaluation efforts of systems as drug development tools
Hepatic and cardiac systems
Key contexts of use in drug evaluation for these systems
Видео A Regulators Viewpoint: Strategies to Evaluate Microphysiological Systems for Drug Development канала CN Bio
Показать
Комментарии отсутствуют
Информация о видео
Другие видео канала
Organ-on-Chip Studies with Physiomimix OOC from CNBio (60 second walkthrough)ALL STEPSCN BIOWEBINAR: Organ on a Chip: Improving Preclinical Studies for Faster Drug DevelopmentBenchtop Organ-on-Chip Device: Physiomimix from CNBio (60 second walkthrough)Organ-on-Chip Studies Workflow Walk-Through (1/6): PhysioMimix T1 from CN BioEngineering Mucosal Barriers: From Organoids to Organs-on-ChipsTesting on Humans: Predict Hepatotoxicity and Drug Clearance Ahead of Clinical Trials Using OOCOrgan-on-Chip Studies Workflow (3/6) Dosing with PhysioMimix T1 from CN BioPhysioMimix™ OOC - Single and multi organ-on-a-chip systemsIntroducing the benefits of a human-relevant organ-on-a-chip approach to drug discovery - CN Bio.We are CN Bio - About UsIntroducing our NEW PhysioMimix HT (Higher Throughput)Predicting the future: humanised drug evaluation testing using organ-on-a-chip technologyOrgan-on-Chip Studies Workflow (5/6) Multi-Organ Analysis with PhysioMimix T1 from CN BioThe Rhythm of Life: Using Microfluidics to Mimic Blood Flow. Single and Multi-Organ-on-a-Chip Models5 Minute Guide to Human Organ-on-Chip Studies: Cells, Tissues, Organs and Multi-Organ ExperimentsHow our PhysioMimix system (Organ-on-a-Chip) worksOrgan-on-Chip Studies Workflow (5/6) Multi-Organ Analysis with PhysioMimix OOC from CN BioGo with the Flow: Application of Microfluidic 3D Liver Chip Models for Genotoxity TestingOrgan-on-Chip Studies Workflow (2/6) Cell Culture with PhysioMimix T1 from CN Bio